Source: BIOSPACE

Cornerstone Therapeutics: Cornerstone Therapeutics Inc. Stockholders Approve Merger

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Craig  Collard 's photo - CEO of Cornerstone Therapeutics, Inc.

CEO

Craig Collard

CEO Approval Rating

70/100

Read more